Status | Study |
Recruiting |
Study Name: Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Condition: Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic) Leptin Receptor Date: 2017-01-03 Interventions: Drug: Setmelanotide RM-493 once daily subcutaneous injection |
Recruiting |
Study Name: Inherited Retinal Degenerative Disease Registry Condition: Eye Diseases Hereditary Retinal Disease Achromatopsia Date: 2015-04-03 |
Recruiting |
Study Name: Clinical Registry Investigating Bardet-Biedl Syndrome Condition: Bardet-Biedl Syndrome Date: 2014-12-26 |
Recruiting |
Study Name: UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource Condition: Hepato/Renal Fibrocystic Disease Autosomal Recessive Polycystic Kidney Disease Date: 2011-07-22 |
Completed |
Study Name: Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults Condition: Bardet-Biedl Syndrome Orphan Diseases Date: 2005-09-13 Interventions: Behavioral: clinical, biological, and radiological |
Terminated |
Study Name: Genetics and Clinical Characteristics of Bardet-Biedl Syndrome Condition: Bardet-Biedl Syndrome Date: 2004-02-18 |
Active, not recruiting |
Study Name: Clinical and Molecular Investigations Into Ciliopathies Condition: Autosomal Recessive Polycystic Kidney Disease Congenital Hepatic Fibrosis Date: 2003-09-10 |